Aptadel Team

Aptadel Therapeutics settles in the Barcelona Science Park and raises $2.1M in Seed Financing Round.

Aptadel Therapeutics, a pre-clinical biomedical company focused on developing a RNA-based platform of targeted therapy delivery to treat cancer, announces the closing of a $2.1M in seed financing. As part of its expansion strategy, the company has also just established its headquarters at the Barcelona Science Park. Aptadel Therapeutics, founded by Dr Oscar Martinez-Tirado of the Bellvitge …

Aptadel Therapeutics settles in the Barcelona Science Park and raises $2.1M in Seed Financing Round. Read More »